Showing results (1031-1040 of 1,361) with videos related to
Sort By:
Pageof 137
Drugs Under Experimental and Clinical Research|January 1, 1985
Long-term coenzyme Q10 therapy: a major advance in the management of resistant myocardial failureS A Mortensen, S Vadhanavikit, U Baandrup, et al.Drugs Under Experimental and Clinical Research|January 1, 1988
Development of gentamicin resistance in gram-negative bacteria in Czechoslovakia and correlation with its usageM Kettner, V KrćméryDrugs Under Experimental and Clinical Research|March 15, 2003
Seijo-bofu-to, Jumi-haidoku-to and Toki-shakuyaku-san suppress rashes and incidental symptoms in acne patientsS Higaki, T Toyomoto, M MorohashiDrugs Under Experimental and Clinical Research|March 15, 2003
KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell lineM Sugimoto, T Inoue, M Yamashita, et al.Drugs Under Experimental and Clinical Research|January 7, 2003
Calcium dobesilate ameliorates lung injury following lower limb ischemia/reperfusionA K Bozkurt, D Konukoğlu, N Ustündağ, et al.Drugs Under Experimental and Clinical Research|January 7, 2003
Inhibitory effects of zafirlukast on respiratory bursts of human neutrophilsP C Braga, M Dal Sasso, R Dal NegroDrugs Under Experimental and Clinical Research|January 7, 2003
The SH-metabolite I of erdosteine, a mucolytic drug, enhances the inhibitory effect of salbutamol on the respiratory burst of neutrophilsM Dal Sasso, C Bovio, M Culici, et al.Drugs Under Experimental and Clinical Research|January 7, 2003
Can losartan improve cardiac performance during the treadmill exercise test in hypertensive subjects?S Paterna, G Parrinello, P Amato, et al.Drugs Under Experimental and Clinical Research|June 21, 2002
Toxicological study of a glucose-added acetic acid maintenance infusion solution (VEEN 3G Inj.) local irritation testK Onodera, M Kawaguch, M Shibata, et al.Drugs Under Experimental and Clinical Research|June 21, 2002
Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect studyF Castellano, G MautonePageof 137